Research Presentations

 
News Articles for Research Presentations top ^
Bristol-Myers Squibb Company (NYSE:BMY) announced today that 16 abstracts for Orencia were accepted for presentation at the 2014 annual meeting of the American College of Rheumatology (ACR) taking place from November 14-19, 2014 in Boston, MA.
Sign-up for Bristol-Myers Squibb to Present Sixteen Orencia (abatacept) Data Abstracts at The American College of Rheumatology (ACR) 2014 Annual Meeting investment picks
Cutrale / Safra's Misleading Statements and Flawed Calculations Fail to Make the Case that their Contingent $13 Per Share Proposal is Adequate CHARLOTTE, N.C., Sept.
Sign-up for Chiquita Sends Letter to Shareholders and Files Investor Presentation to Set Record Straight on Proposed Combination With Fyffes investment picks
2014/11/20
Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on December 4 Canada NewsWire Company invites individual and institutional investors as well as advisors to attend real-time, virtual Retail Investor Conferences Event NEW YORK , Nov.
Sign-up for Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on December 4 investment picks
A late-breaking poster presentation focused on five-year vision data from Lundbeck’s SABRIL (vigabatrin) patient registry was presented at the annual meeting of the American Epilepsy Society (AES). The data set includes 6,823 patients enrolled from August 21, 2009 through August 26, 2014.
Sign-up for Five-Year Data From SABRIL® (vigabatrin) Registry Presented at American Epilepsy Society Annual Meeting investment picks
Fyffes' "Illustrative Value" Nothing More than Attempt to Persuade Chiquita Shareholders to Believe in Mythical Pot of Gold at the End of the Rainbow NEW YORK , Sept.
Sign-up for Cutrale-Safra Responds to Fyffes Investor Presentation investment picks
2014/9/24
Dynex Capital, Inc. (NYSE:DX) announced today that it is scheduled to present at the JMP Securities Financial Services and Real Estate Conference on September 30, 2014 at the St.
Sign-up for Dynex Capital, Inc. to Present at the JMP Securities Financial Services and Real Estate Conference investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that 25 abstracts reporting the results of hepatitis C virus (HCV) treatment regimens containing ABT-450, Enanta’s lead protease inhibitor, or ABT-493, Enanta’s next-generation protease inhibitor, have been accepted for presentation at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), being held November 7-11, 2014 in Boston, MA.
Sign-up for Enanta Pharmaceuticals Announces Data Presentations on Regimens Containing ABT-450 or ABT-493 to be Presented at the American Association for the Study of Liver Diseases (AASLD) investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its development partner Eisai, that clinical data from the ongoing Phase 1 study of EPZ-6438 (E7438), an oral, small molecule inhibitor of EZH2, will be featured in a late-breaking oral presentation at the 26 th EORTC-AACR-NCI Symposium on Molecular Targets and Cancer Therapeutics, to be held November 18-21 in Barcelona, Spain.
Sign-up for Epizyme Announces Clinical Data from Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) to be Presented at EORTC-NCI-AACR Symposium investment picks
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that it will give one oral presentation and two poster presentations on data from its ongoing Phase II and preclinical trials evaluating exon-skipping therapies for the treatment of Duchenne muscular dystrophy (DMD) at the International Congress of the World Muscle Society (WMS), being held from October 7-11, 2014, in Berlin, Germany.
Sign-up for Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of clinical and preclinical data in oral presentation and discussion sessions at the 12 th International Mesothelioma Interest Group (iMig) Conference being held October 22-24, 2014, at the Cape Town International Conference Centre in Cape Town, South Africa.
Sign-up for Verastem Presents New Data on Mesothelioma Programs at the 12th International Mesothelioma Interest Group Meeting investment picks
Health Care REIT, Inc. (NYSE:HCN) today made available updated corporate presentation materials on the Investor Relations section of its website ( www.hcreit.com ). The presentation includes, among other information, financial results from the third quarter of 2014, which the company announced on Tuesday, November 4, 2014.
Sign-up for Health Care REIT, Inc. Releases Updated Corporate Presentation investment picks
Blackbaud, Inc. (NASDAQ: BLKB ), a leading global provider of software and services for the nonprofit, charitable giving and education communities, today announced its senior executives will be giving a company presentation at two upcoming investor conferences: Presentations will be webcast live, available on-demand and archived for a limited time at www.blackbaud.com/investorrelations .
Sign-up for Blackbaud, Inc. Announces Company Presentation at Two Investor Conferences investment picks
2014/10/29
Presenter Features Advanced Wireless Technology, Customizable Modes of Functionality, and Slim Design for User Flexibility and Productivity REDWOOD SHORES, Calif., Oct.
Sign-up for Kensington Introduces PresentAir Pro Bluetooth 4.0 LE for Greater Versatility in Presentation Delivery investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced that study results on investigational agents Opdivo (nivolumab), a PD-1 immune checkpoint inhibitor, elotuzumab, an antibody targeted against Signaling Lymphocyte Activation Molecule (SLAMF7), ulocuplumab, an anti-CXCR4 antibody, and Sprycel (dasatinib), will be featured in oral presentations at the 56th annual meeting of the American Society for Hematology (ASH) in San Francisco from December 6-9, 2014.
Sign-up for Multiple Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 56th Annual American Society for Hematology (ASH) Meeting investment picks
bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Credit Suisse First Boston Bank Health Care Conference on Thursday, November 13, 2014 at 8:00 AM (MST) at the Biltmore Hotel, Phoenix, Arizona.
Sign-up for bluebird bio to Present at Three Upcoming Health Care Conferences investment picks
Fresenius Medical Care North America (FMCNA), the continent’s leading provider of kidney care products and services, announced today that it will be presenting a broad array of clinical research at this year’s American Society of Nephrology (ASN) Kidney Week 2014 conference.
Sign-up for Fresenius Medical Care to Present Extensive Research at the American Society of Nephrology’s Kidney Week 2014 Conference investment picks
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conference: UBS Global Technology Conference Tim Adams, Demandware Chief Financial Officer, will present on Thursday, November 20 th at 8:30 a.m. PST at Cavallo Point, The Lodge at the Golden Gate An audio webcast of the presentation will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executive to Present at Upcoming Investor Conference investment picks
Wells Fargo & Company (NYSE: WFC) said today that Chairman and CEO John Stumpf will present at the Goldman Sachs US Financial Services Conference 2014 in New York on Tuesday, December 9, at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time). The live audio webcast and presentation slides will be available at the following address: www.wellsfargo.com/invest_relations/presents http://cc.talkpoint.com/gold006/120914a_ae/?entity=3_NI0WJJX A replay of the webcast will be available for 180 days.
Sign-up for Wells Fargo to Present at the Goldman Sachs US Financial Services Conference 2014 investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Presentations
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Practice  |  Next: Research Priorities